Oncopeptides' IPO

Oncopeptides raised a round of funding on February 22, 2017. Investors include Public.

Oncopeptides is a clinical stage pharmaceutical development company working to enhance oncology therapies by creating cytosuperiors of existing basic cytotoxic compounds. The company is targeting mult…

Articles about Oncopeptides' IPO: